The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126299922 12629992 2 F 201510 20160812 20160808 20160812 EXP US-PFIZER INC-2016372564 PFIZER 72.00 YR F Y 48.53000 KG 20160812 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126299922 12629992 1 PS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 100 ML, UNK N 18353 100 ML SOLUTION FOR INJECTION
126299922 12629992 2 SS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 100 ML, Q8H (500 MG= 100 ML INJECTION, IVPB, Q8HOUR/ 100 ML/HR INFUSE) N 18353 100 ML SOLUTION FOR INJECTION TID
126299922 12629992 3 SS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 100 ML, UNK (500 MG= 100 ML INJECTION, IVPB, ONCE/ 100 ML/HR, INFUSE OVER 1 HR) N 18353 100 ML SOLUTION FOR INJECTION
126299922 12629992 4 SS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 100 ML, 3X/DAY (500 MG= 100 ML INJECTION, IVPB, Q8HOUR/100 ML/HR INFUSE OVER 1 HR) N 18353 100 ML SOLUTION FOR INJECTION TID
126299922 12629992 5 SS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 UNK N 12623 FILM-COATED TABLET
126299922 12629992 6 SS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 Oral 500 MG, 3X/DAY N 12623 500 MG FILM-COATED TABLET TID
126299922 12629992 7 SS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 Oral 500 MG, 3X/DAY (X 7 DAY) N 12623 500 MG FILM-COATED TABLET TID
126299922 12629992 8 C ACETAMINOPHEN AND CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 Oral UNK (ACETAMINOPHEN 300 MG/ CODEINE 30 MG, 1-2 TABLETS EVERY FOUR HOURS) 0
126299922 12629992 9 C XANAX ALPRAZOLAM 1 UNK 0
126299922 12629992 10 C METOPROLOL. METOPROLOL 1 Oral 50 MG, DAILY 0 50 MG PROLONGED-RELEASE TABLET
126299922 12629992 11 C ATORVASTATIN ATORVASTATIN 1 20 MG, UNK 0 20 MG
126299922 12629992 12 C GABAPENTIN. GABAPENTIN 1 UNK 0
126299922 12629992 13 C CIPROFLOXACIN. CIPROFLOXACIN 1 Intravenous (not otherwise specified) 200 UNK,(400 MG= 200 MLINJECTION, IVPB, Q12HOUR / INFUSE OVER 1 HR, 200) 0 200 ML INJECTION
126299922 12629992 14 C CIPROFLOXACIN. CIPROFLOXACIN 1 Intravenous (not otherwise specified) 200 ML, 2X/DAY (400 MG= 200 ML INJECTION, IVPB, Q12HOUR/ 200 ML/HR/ INFUSE OVER 1 HR) 0 200 ML INJECTION BID
126299922 12629992 15 C CIPROFLOXACIN. CIPROFLOXACIN 1 200 ML, SINGLE (400 MG = 200 ML INJECTION, IVPB, ONCE/200 ML/HR, INFUSE OVER 1 HR ) 0 200 ML INJECTION
126299922 12629992 16 C AFRIN OXYMETAZOLINE 1 Nasal UNK UNK, AS NEEDED (1 SPRAY SPRAY, NASAL, Q12HOUR, PRN ) 0 NASAL SPRAY, SOLUTION
126299922 12629992 17 C LACTATED RINGERS CALCIUM CHLORIDEPOTASSIUM CHLORIDESODIUM CHLORIDESODIUM LACTATE 1 Intravenous (not otherwise specified) 125 ML, UNK (1,000 ML, BAG, IV, 125 ML/HR, INFUSE OVER: 8 HR) 0 125 ML SOLUTION FOR INFUSION
126299922 12629992 18 C METOPROLOL SUCCINATE. METOPROLOL SUCCINATE 1 Oral 50 MG, DAILY 0 50 MG PROLONGED-RELEASE TABLET
126299922 12629992 19 C ONDANSETRON ONDANSETRON 1 Intravenous (not otherwise specified) 2 UNK, UNK (4 MG = 2 ML INJECTION, IV PUSH, Q6HOUR, PRN ) 0 2 ML INJECTION
126299922 12629992 20 C ONDANSETRON ONDANSETRON 1 0 INJECTION
126299922 12629992 21 C CIPRO CIPROFLOXACIN HYDROCHLORIDE 1 Oral 500 MG, 2X/DAY (DURATION 8 DAY) 0 500 MG TABLET BID
126299922 12629992 22 C MIRALAX POLYETHYLENE GLYCOL 3350 1 Oral 17 G, 2X/DAY (17 GM= 1 EA REC POWDER) 0 17 G BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126299922 12629992 5 Diverticulitis
126299922 12629992 8 Pain
126299922 12629992 16 Nasal congestion
126299922 12629992 19 Nausea
126299922 12629992 20 Vomiting

Outcome of event

Event ID CASEID OUTC COD
126299922 12629992 HO
126299922 12629992 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126299922 12629992 Diverticulitis
126299922 12629992 Hypoaesthesia
126299922 12629992 Neuropathy peripheral
126299922 12629992 Pain in extremity

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126299922 12629992 1 20151008 20151022 0
126299922 12629992 2 20151008 0
126299922 12629992 3 20151008 0
126299922 12629992 4 20151009 0
126299922 12629992 5 20151022 0
126299922 12629992 6 20151014 0
126299922 12629992 7 20151016 0
126299922 12629992 10 20151016 0
126299922 12629992 13 20151009 0
126299922 12629992 14 20151009 0
126299922 12629992 15 20151008 0
126299922 12629992 16 20151008 20151011 0
126299922 12629992 17 20151008 0
126299922 12629992 18 20151016 0
126299922 12629992 19 20151008 0
126299922 12629992 21 20151014 0
126299922 12629992 22 20151014 0